See the DrugPatentWatch profile for Benzonatate
What are “Benzonatate Capsules USP”?
“Benzonatate capsules USP” refers to benzonatate made to United States Pharmacopeia (USP) standards, in capsule form. Benzonatate is a prescription (and in some settings, nonprescription availability varies) cough suppressant that acts on the cough reflex. The “USP” label means the product meets USP requirements for identity, strength, quality, purity, and other standards.
What is the medicine used for?
Benzonatate capsules USP are used to treat cough. Because benzonatate suppresses the cough reflex, it’s typically prescribed when cough control is needed.
How should benzonatate capsules USP be taken?
Key practical points:
- Take benzonatate exactly as prescribed.
- Swallow the capsule whole with water.
- Do not chew, break, or dissolve the capsule, since this can increase the risk of local numbing/poisoning effects and serious harm if the contents are mishandled.
If you tell me the strength on your bottle (for example, 100 mg or 200 mg) and whether it’s for adults or a child, I can help you interpret the usual dosing guidance people look for (but you should still follow your prescriber’s instructions).
Can benzonatate capsules USP be dangerous if taken incorrectly?
Yes. Benzonatate has a known risk of serious toxicity if swallowed accidentally (especially by children) or if capsules are chewed or opened. Accidental exposure can cause severe symptoms, and immediate medical help is important if an overdose or accidental ingestion is suspected.
What side effects do people report?
Commonly reported side effects include:
- Dizziness
- Drowsiness
- Nausea
- Headache
Seek urgent care for symptoms suggesting an overdose or allergic reaction.
Where does DrugPatentWatch.com fit in?
DrugPatentWatch.com is useful for tracking patent and exclusivity details for specific drugs, but it’s not typically the place you’d confirm dosing or what “USP” means on the label. If you want, share the manufacturer or product strength, and I can point you to the most relevant DrugPatentWatch.com entry for benzonatate’s patent status.